Correlation Between Hyundai and AcelRx Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Hyundai and AcelRx Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Hyundai and AcelRx Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Hyundai Motor Co and AcelRx Pharmaceuticals, you can compare the effects of market volatilities on Hyundai and AcelRx Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Hyundai with a short position of AcelRx Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Hyundai and AcelRx Pharmaceuticals.
Diversification Opportunities for Hyundai and AcelRx Pharmaceuticals
-0.69 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Hyundai and AcelRx is -0.69. Overlapping area represents the amount of risk that can be diversified away by holding Hyundai Motor Co and AcelRx Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AcelRx Pharmaceuticals and Hyundai is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Hyundai Motor Co are associated (or correlated) with AcelRx Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AcelRx Pharmaceuticals has no effect on the direction of Hyundai i.e., Hyundai and AcelRx Pharmaceuticals go up and down completely randomly.
Pair Corralation between Hyundai and AcelRx Pharmaceuticals
Assuming the 90 days horizon Hyundai Motor Co is expected to generate 0.39 times more return on investment than AcelRx Pharmaceuticals. However, Hyundai Motor Co is 2.57 times less risky than AcelRx Pharmaceuticals. It trades about 0.07 of its potential returns per unit of risk. AcelRx Pharmaceuticals is currently generating about -0.06 per unit of risk. If you would invest 2,854 in Hyundai Motor Co on August 31, 2024 and sell it today you would earn a total of 2,846 from holding Hyundai Motor Co or generate 99.72% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 28.51% |
| Values | Daily Returns |
Hyundai Motor Co vs. AcelRx Pharmaceuticals
Performance |
| Timeline |
| Hyundai Motor |
| AcelRx Pharmaceuticals |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Hyundai and AcelRx Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Hyundai and AcelRx Pharmaceuticals
The main advantage of trading using opposite Hyundai and AcelRx Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Hyundai position performs unexpectedly, AcelRx Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AcelRx Pharmaceuticals will offset losses from the drop in AcelRx Pharmaceuticals' long position.The idea behind Hyundai Motor Co and AcelRx Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| AcelRx Pharmaceuticals vs. Lifecore Biomedical | AcelRx Pharmaceuticals vs. Shuttle Pharmaceuticals | AcelRx Pharmaceuticals vs. Catalent | AcelRx Pharmaceuticals vs. Tilray Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Complementary Tools
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |